StockData

Elanco Animal Health vs Organon

ELAN and OGN side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How ELAN and OGN compare

Elanco Animal Health is the larger company, worth 3.5 times as much as Organon ($12.9B against $3.7B).

Elanco Animal Health grew revenue faster over the last twelve months (12.0% versus −3.2% for Organon).

Organon keeps more of each dollar of sales as profit, with a net margin of 3.5% compared with −4.0% at Elanco Animal Health.

Organon pays a dividend yielding 0.58%; Elanco Animal Health does not pay one.

Elanco Animal Health scores higher on the StockData Score (9 against 7 for Organon), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricELANOGN
Size and price
Market cap$12.9B$3.7B
Share price$25.85$13.90
Change, 1 year22.6%84.6%
Change, 5 years−14.5%−55.3%
Beta (5Y)0.122.21
Employees9,40010K
StockData Score
Total score9 (better)7
Valuation score11
Growth score3 (better)0
Performance score3 (better)2
Health score2 (better)1
Dividend score03 (better)
Valuation
P/E–18.1×
P/S2.6×0.6× (better)
P/B2.0× (better)3.1×
EV/EBITDA30.9×–
P/FCF34.1×5.4× (better)
FCF yield2.9%18.5% (better)
Fair value$11.31$12.32
Margin of safety−129%−12.8% (better)
Growth
Revenue growth (TTM)12.0% (better)−3.2%
Revenue growth, 5Y average7.6% (better)−0.99%
Net income growth (TTM)−146%−57.5% (better)
EPS growth (TTM)−149%−59.9% (better)
EPS growth, 5Y average–−39.0%
Profitability
Gross margin55.4% (better)53.1%
Net margin−4.0%3.5% (better)
FCF margin7.5%11.1% (better)
Return on equity−3.0%20.3% (better)
Financial health
Debt / equity0.59 (better)7.17
Net debt / EBITDA6.43–
Current ratio2.05 (better)2.02
Altman Z-score1.44 (better)1.04
Piotroski F-score6 (better)5
Dividends and buybacks
Dividend yield–0.58%
Payout ratio–9.4%
Years of dividend growth–0
Shareholder yield0.00%0.58% (better)
Ownership
Held by institutions113%83.3%
Held by insiders1.1%0.49%
Insider net buying, 12 months$2.5M (better)−$200K
Short interest, % of float6.7%7.5%

Go deeper

Other comparisons

For information only, not investment advice. Check the source filings before relying on any figure.